With Andrew Shaughnessy, Peter Wilcox
On November 3, 2006, a unanimous Supreme Court of Canada released a decision (AstraZeneca Canada Inc. v. Canada (Minister of Health)1) that may have significant implications for innovator pharmaceutical companies.